1. John Nemunaitis is Executive Medical Director of Mary Crowley Cancer Research Centers (TX, USA). He has been exploring novel targeted therapies for treating cancer patients for over 20 years. His research focus is clinical in orientation and involves determination of molecular signals in order to optimize targeted therapy, development of RNAi-based therapeutics and cancer vaccine approaches.